Finland· FI-REL-REL484

Sofradex

A dexamethason und antiinfektiva product containing gramicidin + framycetin sulfate + dexamethasone sodium metasulfobenzoate, registered in Finland by sanofi-aventis Oy. The same ATC class is registered in 2 of our 19 countries.

ATC S03CA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSofradexATCS03CA01REGISTER NO.FI-REL-REL484PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Dexamethason und antiinfektiva is registered in 2 of 19 countries.

Countries holding a registration under ATC S03CA01 (dexamethason und antiinfektiva), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Dexamethason und antiinfektiva · ATC S03CA01

2 / 19 countries

  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Gramicidin + Framycetin sulfate + Dexamethasone sodium metasulfobenzoate
Manufacturer
sanofi-aventis Oy
Country
Finland (FI)
ATC code
S03CA01
ATC class
Dexamethason und Antiinfektiva
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexamethason und antiinfektiva in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexamethason und antiinfektiva products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Netherlands · Sofradex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/efcdf50c-be0e-4828-a4d7-244ab000774c
GET /v1/drugs/efcdf50c-be0e-4828-a4d7-244ab000774c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "silmä/korvatipat",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "deksametasoni ja mikrobilääkkeet",
  "ma_number": "4506",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL484",
  "authorised_at": "1967-02-08"
}

See everything about dexamethason und antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.